infliximab-dyyb

CHEBI:CHEBI_746972

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1790546
product_type
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
route
INTRAVENOUS
marketing_start_date
20160808
package_marketing_start_date
21-NOV-16
marketing_category
BULK INGREDIENT
nui
N0000175451
pharm_class_epc
Tumor Necrosis Factor Blocker [EPC]
pharm_class
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
pharm_class_moa
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
generic_name
infliximab-dyyb
brand_name
INFLECTRA
brand_name_base
INFLECTRA
product_ndc
32228-002
application_number
BLA125544
labeler_name
CELLTRION, Inc.
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
spl_id
afe80511-7013-4a7f-b4ec-2ad374b87218
active_ingredient_name
INFLIXIMAB-DYYB
active_ingredient_strength
9 kg/9kg
package_ndc
32228-002-04
package_description
1 BOTTLE in 1 BOX (32228-002-04) / 4.706 kg in 1 BOTTLE
unii
B72HH48FLU
spl_set_id
37eaca10-d812-48bc-8b8e-b836bfa9968f
upc
0300690809014
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class